A 52-year-old man from Delhi presents with fatigue and melena for 3 weeks. He denies any previous GI symptoms or weight loss. Hemoglobin is 8.5 g/dL, MCV 68 fL, RDW 18%. Serum ferritin is 8 ng/mL, serum iron 40 μg/dL, TIBC 440 μg/dL. Upper endoscopy reveals a bleeding gastric ulcer. After treatment of the ulcer, iron supplementation is started. Which of the following findings would indicate an adequate hematologic response to iron therapy at 4 weeks?

Explanation

## Iron Deficiency Anemia: Response to Iron Therapy ### Clinical Scenario This patient has iron deficiency anemia secondary to acute GI blood loss (gastric ulcer). Iron supplementation has been initiated. The question asks for the **earliest hematologic marker of adequate response** at 4 weeks. ### Timeline of Hematologic Response to Iron Therapy ```mermaid flowchart TD A["Iron supplementation started"]:::action --> B["Days 3–5: Reticulocytosis begins"]:::outcome B --> C["Weeks 1–2: Reticulocyte peak 2–6%"]:::outcome C --> D["Weeks 2–4: Hemoglobin rises 1–2 g/dL"]:::outcome D --> E["Weeks 4–8: MCV normalizes"]:::outcome E --> F["Weeks 8–12: Ferritin replenishes"]:::outcome F --> G["Weeks 12–16: Complete hematologic recovery"]:::outcome style A fill:#e8f5e9 style B fill:#e3f2fd style C fill:#e3f2fd style D fill:#e3f2fd style E fill:#fff3e0 style F fill:#fff3e0 style G fill:#f3e5f5 ``` ### Early Response Markers (4 weeks) **Key Point:** At 4 weeks, the **earliest and most reliable sign of adequate iron therapy response is reticulocytosis (>2%) accompanied by a hemoglobin rise of 1–2 g/dL**. | Timeline | Finding | Mechanism | |----------|---------|----------| | **Days 3–5** | Reticulocytosis begins | Iron enters erythroid precursors; increased RBC production | | **Weeks 1–2** | Reticulocyte peak (2–6%) | Maximum bone marrow response | | **Weeks 2–4** | Hemoglobin ↑ 1–2 g/dL | Increased circulating RBC mass | | **Weeks 4–8** | MCV normalizes | Synthesis of normal-sized RBCs | | **Weeks 8–12** | Ferritin normalizes | Iron stores replenish | **High-Yield:** **Reticulocytosis is the FIRST sign of response to iron therapy**. A reticulocyte count >2% (normal 0.5–2%) within 1–2 weeks indicates adequate iron absorption and bone marrow response. Hemoglobin rise of 1–2 g/dL over 2–4 weeks follows. ### Why Reticulocytosis Occurs 1. Oral/parenteral iron is absorbed and transported to bone marrow 2. Iron enters mitochondria of erythroid precursors (CFU-E, normoblasts) 3. Heme synthesis resumes → hemoglobin production increases 4. Immature RBCs (reticulocytes) are released prematurely from marrow 5. Reticulocyte count rises before hemoglobin normalizes **Clinical Pearl:** A **failure of reticulocytosis** at 2 weeks suggests: - Poor compliance - Malabsorption (celiac disease, H. pylori) - Ongoing blood loss exceeding iron replacement - Incorrect diagnosis (not true iron deficiency) ### Mnemonic: FERRIC Response - **F** — Ferritin (last to normalize, weeks 8–12) - **E** — Early reticulocytosis (days 3–5) - **R** — RBC count rises (weeks 2–4) - **R** — RBC size (MCV) normalizes (weeks 4–8) - **I** — Iron studies improve (weeks 4–8) - **C** — Complete recovery (weeks 12–16)